- Home
- RIGL vs PSTL Comparison
RIGL vs PSTL Comparison
Compare RIGL & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- PSTL
- Stock Information
- Founded
- RIGL 1996
- PSTL 2018
- Country
- RIGL United States
- PSTL United States
- Employees
- RIGL N/A
- PSTL N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- RIGL Health Care
- PSTL Real Estate
- Exchange
- RIGL Nasdaq
- PSTL Nasdaq
- Market Cap
- RIGL 335.5M
- PSTL 329.8M
- IPO Year
- RIGL 2000
- PSTL 2019
- Fundamental
- Price
- RIGL $18.41
- PSTL $14.98
- Analyst Decision
- RIGL Buy
- PSTL Strong Buy
- Analyst Count
- RIGL 5
- PSTL 1
- Target Price
- RIGL $36.40
- PSTL $16.50
- AVG Volume (30 Days)
- RIGL 170.2K
- PSTL 168.5K
- Earning Date
- RIGL 08-05-2025
- PSTL 08-05-2025
- Dividend Yield
- RIGL N/A
- PSTL 6.34%
- EPS Growth
- RIGL N/A
- PSTL 176.54
- EPS
- RIGL 2.08
- PSTL 0.28
- Revenue
- RIGL $203,077,000.00
- PSTL $81,235,000.00
- Revenue This Year
- RIGL $14.41
- PSTL $19.86
- Revenue Next Year
- RIGL $15.97
- PSTL $10.14
- P/E Ratio
- RIGL $8.92
- PSTL $54.12
- Revenue Growth
- RIGL 70.16
- PSTL 23.36
- 52 Week Low
- RIGL $7.48
- PSTL $12.26
- 52 Week High
- RIGL $29.82
- PSTL $15.42
- Technical
- Relative Strength Index (RSI)
- RIGL 37.91
- PSTL 64.06
- Support Level
- RIGL $18.35
- PSTL $14.57
- Resistance Level
- RIGL $19.21
- PSTL $15.42
- Average True Range (ATR)
- RIGL 0.89
- PSTL 0.29
- MACD
- RIGL -0.33
- PSTL 0.02
- Stochastic Oscillator
- RIGL 2.15
- PSTL 67.28
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.